Released Mar 29, 2024, during market hours
10-K filed Mar 29, 2024, 89 days after period end · 0001437749-24-010029
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.26M$2.26M derived+0.9% vs Q4 2022+9.8% vs Q3 2023
Net Income-$1.94M-$1.94M derivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,509,656+39.1%
Operating Incomederived-$1,979,543N/M
Operating Cash Flowderived-$1,245,799N/M
Margins · derived
Gross margin66.8%+18.4 pt vs Q4 2022
Operating margin-87.6%+2.3 pt vs Q4 2022
Net margin-85.8%+2.3 pt vs Q4 2022
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.26M | $2.24M | $2.85M | $2.21M |
| Net Income | -$1.94M | -$1.97M | -$1.12M | -$1.08M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Scientific Inc. · CIK 855683 · Engraved from SEC EDGAR